Do you ever multi task at a job? Or at home? You can’t do more than one thing in a day? Apparently MK can multi task and delegate assignments accordingly. That’s what a CEO does. Working to advance IsoPet has not changed the path trajectory of IDE submission. We would still be on this same path and time line without IsoPet. In fact, without IsoPet we would more likely be further behind as we would not have the collective data obtained from IsoPet development. Also, given the success rate of IsoPet treatment, I would say that gives further investor confidence going into clinical trials.